Lipidic nanoparticles in combined chemotherapy: in vivo inhibition of melanoma B16F10 growth (2009)
Source: Abstracts. Conference titles: Annual Meeting of the American Association for Cancer Research (AACR). Unidade: FCF
Subjects: NANOPARTÍCULAS, QUIMIOTERAPIA, MELANOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KRETZER, Iara Fabricia et al. Lipidic nanoparticles in combined chemotherapy: in vivo inhibition of melanoma B16F10 growth. 2009, Anais.. Philadelphia: American Association for Cancer Research, 2009. . Acesso em: 21 out. 2024.APA
Kretzer, I. F., Maria, D. A., Valduga, C. J., Contente, T. C., & Maranhão, R. C. (2009). Lipidic nanoparticles in combined chemotherapy: in vivo inhibition of melanoma B16F10 growth. In Abstracts. Philadelphia: American Association for Cancer Research.NLM
Kretzer IF, Maria DA, Valduga CJ, Contente TC, Maranhão RC. Lipidic nanoparticles in combined chemotherapy: in vivo inhibition of melanoma B16F10 growth. Abstracts. 2009 ;[citado 2024 out. 21 ]Vancouver
Kretzer IF, Maria DA, Valduga CJ, Contente TC, Maranhão RC. Lipidic nanoparticles in combined chemotherapy: in vivo inhibition of melanoma B16F10 growth. Abstracts. 2009 ;[citado 2024 out. 21 ]